Portal de Periódicos da CAPES

Table of Contents

2022; Elsevier BV; Volume: 142; Linguagem: Inglês

10.1016/s0895-4356(22)00005-1

1878-5921

David Tovey, Peter Commentaries, Ralph I. Horwitz, Gabriella Lobitz, McKayla Mawn, Allison Hayes‐Conroy, Mark R. Cullen, Ida Sim, Burton H. Singer, Nathan Ford, Rebekah Thomas, John W. Grove, Rafael Leite Pacheco, Ana Lúiza, Cabrera Martimbianco, Rachel Riera, Liam Mccoy, Connor T. A. Brenna, Stacy S. Chen, Karina Vold, Sunit Das, H Leufkens, Tim Morris, Maarten van Smeden, Jean Digitale, Jeffrey Martin, M. Maria Glymour, Carlos A. Cuello‐García, Nancy Santesso, Rebecca Morgan, Jos Verbeek, Kris Thayer, Mohammed Ansari, Joerg J Meerpohl, Lukas Schwingshackl, Vittal Srinivasa, Jan Katikireddi, Barnaby Brozek, Mohammad Reeves, Maicon Murad, Reem Falavigna, Deborah Mustafa, E. Paul, Paul Alexander, Elie Garner, Gordon Akl, Holger Guyatt, Qi Wang, Ya Xiao, Taotao Guo, Hongfei Zhu, Jieyun Li, Honghao Lai, Ying Zhang, Fengwen Yang, Yu Liu, Kehu Yang, Yaolong Chen, Jinhui Tian, Guowu Ding, Long Ge, Jadbinder Seehra, Kristina Bertl, Clóvis Mariano Faggion, Nikolaos Pandis, Margarita Ravinskaya, Miranda Langendam, Joost G. Daams, Carel Hulshof, Ira Madan, Suzanne Verstappen, Marije Hagendijk, Regina Kunz, Jan W. Hoving,

Missing trials in drug regulatory dossiers may have good reasons, but should be predefined and transparent